June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Stability study of Amniotic-membrane-derived lumican at different storage temperatures, as a potential eye drops treatment
Author Affiliations & Notes
  • Luis Haro-Morlett
    Biologia Celular y Tisular, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico City, Mexico
  • Beatriz Buentello-Volante
    Biologia Celular y Tisular, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico City, Mexico
  • Emilio Iturriaga-Goyon
    Biologia Celular y Tisular, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico City, Mexico
  • Paola Sanchez-Cisneros
    Biologia Celular y Tisular, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico City, Mexico
  • Jose Eduardo Aguayo-Flores
    Biologia Celular y Tisular, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico City, Mexico
  • Isabel de la Fuente-Bata
    Biologia Celular y Tisular, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico City, Mexico
  • Carlos Adolfo Müller-Morales
    Cornea, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico City, Mexico
  • Alejandro Navas
    Cornea, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico City, Mexico
  • Enrique O Graue-Hernandez
    Cornea, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico City, Mexico
  • Fatima Sofia Magana-Guerrero
    Biologia Celular y Tisular, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico City, Mexico
  • Yonathan Garfias
    Biologia Celular y Tisular, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico City, Mexico
  • Footnotes
    Commercial Relationships   Luis Haro-Morlett None; Beatriz Buentello-Volante None; Emilio Iturriaga-Goyon None; Paola Sanchez-Cisneros None; Jose Eduardo Aguayo-Flores None; Isabel de la Fuente-Bata None; Carlos Müller-Morales None; Alejandro Navas None; Enrique Graue-Hernandez None; Fatima Sofia Magana-Guerrero None; Yonathan Garfias None
  • Footnotes
    Support  PAPIIT IN203821; SECTEI 250/2019
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3227 – A0262. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Luis Haro-Morlett, Beatriz Buentello-Volante, Emilio Iturriaga-Goyon, Paola Sanchez-Cisneros, Jose Eduardo Aguayo-Flores, Isabel de la Fuente-Bata, Carlos Adolfo Müller-Morales, Alejandro Navas, Enrique O Graue-Hernandez, Fatima Sofia Magana-Guerrero, Yonathan Garfias; Stability study of Amniotic-membrane-derived lumican at different storage temperatures, as a potential eye drops treatment. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3227 – A0262.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Lumican is a small leucine rich proteoglycan present in the human amniotic membrane (AM) that promotes corneal epithelialization. The aim of the present study was determining whether lumican can be extracted from AM and evaluating its stability as AM extract (AME) stored at different temperatures, which could help design epitheliazing-eye drops.

Methods : One-hundred mg of AM were incubated with dispase II at 37°C for 30 min and mechanically de-epithelialized. The de-epithelialized AM was washed and immersed in liquid nitrogen for 40 min, then crushed until a fine powder was obtained, which was solubilized with 2.5 ml of saline buffer with protease inhibitors and centrifuged. Supernatant was collected and stored at -20°C, 4°C and room temperature (RT) for 6, 12, 20 and 32 days until lumican quantitation. Lumican was calculated in each sample according with: [ng/ml lumican / mg of AM tissue].

Results : We obtained similar protein concentrations among all the AME at basal protein quantification. There was no significant difference between protein concentration and time of storage; however, we found significant differences (p<0.05) between the AME of 32- and 20-days with respect their basal protein concentration. After that, we analyzed protein concentration with storage temperature, and found significant differences (p<0.05) in the AME of 32 days at 4°C and -20°C respect the RT condition, similarly the AME of 20 days had significant results at -20°C respect other temperature conditions. The quantification of lumican in AME showed that the concentration was affected by time of storage and temperature conditions. Lumican in the AME of 12 days was significantly higher (p<0.05) in comparison with the AME of 32, 20 and 6 days. There was no differences between lumican in the AME of 32 and 20 days with respect the temperature conditions of storage. Interestingly, when we analyzed the AME of 12 days we significantly (p<0.05) observed a high proportion of lumican in temperature conditions of -20°C and 4°C with respect of RT and -70°C. Similarly, we found a significant difference of lumican in the AME of 6 days stored at -20°C, respect other temperatures.

Conclusions : Lumican can be extracted from AM and stored for 12 days as AME, at both temperature conditions of -20°C and 4°C. Further studies are needed to determine AME lumican’s function on corneal epithelial cells.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×